Saturday, 08 August 2020

Agilent, Trivitron to setup high-end lab in IIT Chennai

06 September 2013 | News | By BioSpectrum Bureau

Agilent Technologies and Trivitron Healthcare will establish a world class Partner Lab in IIT Chennai, India

Agilent Technologies and Trivitron Healthcare will establish a world class Partner Lab in IIT Chennai, India

Bangalore: Agilent Technologies India and Trivitron Healthcare are going to establish a world class Partner Lab within the campus of IIT Chennai Science Park. As a part of this association, the Partner lab will be equipped with high end technologies, including UHPLC, LC MS/MS, qPCR's from Agilent.

Trivitron plans to use these to develop end-to-end solutions using analytical platforms in a cost effective way making them accessible and affordable for clinical testing markets in emerging countries like India.

Commenting on this collaboration, Dr Pasupathi Siva Kumar, country manager, life science group and chemical analysis group, Agilent, India, said, "The healthcare sector is extremely important for a country especially like India. There is a constant need to introduce newer technologies in the area of clinical research that will enable the diagnosis of disease more accurately and at a more rapid pace. As a part of the association, Agilent will provide its latest analytical technologies to establish a world class lab within the campus of IIT Chennai Science Park. With this collaboration with Trivitron Healthcare we hope to ensure better health preparedness for the Indian population"

Dr GSK Velu, MD, Trivitron Healthcare, India, said that, "With three of the world class manufacturing facilities for IVD Reagents located in India and Finland, partnership with world leader Agilent Technologies for Instrument platforms will enable us to offer a wider specialized area of clinical testing and is a great addition to Trivitron's portfolio."

He further added, "With the benefit of Agilent's analytical capabilities and expertise, Trivitron will work to innovate and develop Diagnostics kits in several areas like carrier screening, pre natal screening, new born screening, drug monitoring, vitamin profiling, biogenic amines, homocysteine, and carbohydrate deficient transferrin (CDT). Three decades of expertise and R&D experience of Trivitron's subsidiary Labsystems Diagnostics, Finland, will act as a catalyst for this collaboration using Agilent's high end analytical technologies."

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account



Survey Box

Should we be cautious of viewing COVID-19 vaccine as silver bullet?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls